Checkpoint antibody receptor modified ARMed CAR T circumvents the suppressive immunome in GBM by Danielle R. Cook, Alina C. Boesteanu, Yibo Yin, Yibo Yin, Reiss Reid, Laura Roccograndi, Nadia Dahmane, Maria Martinez-Lage, Donald M. O’Rourke, Carl H. June, Carl H. June, Laura A. Johnson, Laura A. Johnson

Get full text

Multiplex engineering using microRNA-mediated gene silencing in CAR T cells by Giulia Golinelli, Giulia Golinelli, John Scholler, Audrey Roussel-Gervais, Antonija Šakić, Sten Ilmjärv, Decheng Song, Khatuna Gabunia, Mei Ji, Ting J. Fan, Aasha Gupta, Mansi Deshmukh, Abdulla Berjis, Abdulla Berjis, Riccardo Cuoghi Costantini, Kimberly Apodaca, Neil C. Sheppard, Sven Kili, Massimo Dominici, Marco Alessandrini, Carl H. June, Carl H. June, Carl H. June, Bruce L. Levine

Get full text

Format-tuning of in vivo-launched bispecific T cell engager enhances efficacy against renal cell carcinoma by Carl H June, David Weiner, Christopher A Chuckran, Daniel Park, Ryan P O’Connell, Kevin Liaw, Nils Wellhausen, Pratik S Bhojnagarwala, Devivasha Bordoloi, Nicholas Shupin, Daniel Kulp

Get full text

Zelig Eshhar (1941–2025): a tribute for a life for immunotherapy by Carl H June, Steven A Rosenberg, Crystal Mackall, Michel Sadelain, James P Allison, Eric Smith, Michael T Lotze, Marcela V Maus, Hinrich Abken, Renier Brentjens, Robbie G Majzner

Get full text

Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancer by Jeffrey Schlom, Carl H. June, George A. Fisher, John J. Nemunaitis, Kristen M. Hege, Emily K. Bergsland, Robert S. Warren, James G. McArthur, Andy A. Lin, Stephen A. Sherwin

Get full text

Distinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cells. by Richard G Carroll, Carmine Carpenito, Xiaochuan Shan, Gwenn Danet-Desnoyers, Ronghua Liu, Shuguang Jiang, Steven M Albelda, Tatiana Golovina, George Coukos, James L Riley, Zdenka L Jonak, Carl H June

Get full text

Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. by Shoba Amarnath, Carliann M Costanzo, Jacopo Mariotti, Jessica L Ullman, William G Telford, Veena Kapoor, James L Riley, Bruce L Levine, Carl H June, Timothy Fong, Noel L Warner, Daniel H Fowler

Get full text

Intentional heterogeneity in autologous cell-based gene therapies: strategic considerations for first-in-human trials by Antoni Ribas, Carl H June, Philip D Greenberg, Crystal L Mackall, Marcela V Maus, John E Connolly, Christopher R Cabanski, Ute Dugan, Mark D Stewart, Jeff D Allen, EnJun Yang, Alexander Marson

Get full text

LOXHD1 is an oncofusion-regulated antigen of ewing sarcoma by Tatiana Blanchard, Pouya Faridi, Chong Xu, Adham S. Bear, Reyaz ur Rasool, Grace Huang, Terry C. C. Lim, Rochelle Ayala, Khatuna Gabunia, Mei Ji, Avery D. Posey, John Scholler, Irfan A. Asangani, Anthony W. Purcell, Gerald P. Linette, Carl H. June, Beatriz M. Carreno

Get full text

CD22-targeted chimeric antigen receptor-modified T cells for children and adults with relapse of B-cell acute lymphoblastic leukemia after CD19-directed immunotherapy by Clare Taylor, Carl H June, Joseph A Fraietta, Boris Engels, Gabriela Plesa, Marco Ruella, Stephan A Grupp, Hongyan Liu, Colleen Callahan, Shannon L Maude, Regina M Myers, Caroline Diorio, Yimei Li, Vanessa Gonzalez, Julie K Jadlowsky, Amanda M DiNofia, Gerald Wertheim, Donald L Siegel, Emma Iannone, Laura Shinehouse, Jennifer L Brogdon, Elizabeth O Hexner, Diane Baniewicz, Richard Aplenc, Allison Barz Leahy, Susan E McClory, Susan R Rheingold, Lisa Wray, Noelle V Frey

Get full text